Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance- A review

Pathol Res Pract. 2023 May:245:154438. doi: 10.1016/j.prp.2023.154438. Epub 2023 Apr 6.

Abstract

Pancreatic cancer (PC) is one of the deadliest cancers associated with poor prognosis. The lack of reliable means of early cancer detection contributes to this disease's dismal prognosis. Long non-coding RNAs (LncRNAs) are protein-free RNAs produced by genome transcription; they play critical roles in gene expression regulation, epigenetic modification, cell proliferation, differentiation, and reproduction. Recent research has shown that lncRNAs play important regulatory roles in PC behaviors, in addition to their recently found functions. Several in-depth investigations have shown that lncRNAs are strongly linked to PC development and progression. Here, we discuss how lncRNAs, which are often overlooked, play many roles as regulators in the molecular mechanism underlying PC. This review also discusses the involved LncRNAs in PC pathogenesis and treatment resistance.

Keywords: LncRNA; Pancreatic cancer; Pathogenesis; Treatment resistance.

Publication types

  • Review

MeSH terms

  • Cell Differentiation
  • Gene Expression Regulation, Neoplastic / genetics
  • Humans
  • Pancreatic Neoplasms* / genetics
  • Pancreatic Neoplasms* / metabolism
  • Pancreatic Neoplasms* / therapy
  • Prognosis
  • RNA, Long Noncoding* / genetics
  • RNA, Long Noncoding* / metabolism

Substances

  • RNA, Long Noncoding